Dimerix Health Care
Biotech Healthcare Pharmaceuticals

$0.062 0.002 (3.33%)

High $0.06	Low $0.06	Trades 18	Turnover $32,113	Volume 526,676
30 June 2023 at 3:59pm

Market Cap (5-Aug) $174,115,072 (1,050th)	Close (30-Jun) $0.062 0 (0%)	Volume (30-Jun) 526,676	Shortsold (31-Jul) 83,488 (0.01%) (558th)
52w High $0.67	52w Low $0.158	P/E 10.78	EPS -0.03

Short Interest

ASIC data, 31 Jul 2026

% Shorted

0.01% 0.00

vs 0.02% prior report

Most Shorted Rank

558th

of 708 shorted ASX stocks

Peak Short

0.50%

Mar 2025

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	DXB DXB Ann: Constitution
	1 (current) 2 3
	DXB DXB Ann: Results of Meeting
	DXB DXB Ann: Chair address and CEO presentation to AGM
	DXB DXB Ann: Investor Briefing
	DXB DXB Ann: Letter to Shareholders, Notice of AGM & Proxy Form
	DXB DXB Ann: AusBioInvest Presentation, including FSGS recruitment update
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: Dimerix Receives A$6.0M R&D Tax Incentive Rebate
	DXB DXB Ann: Notification of Date of 2022 AGM
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Appendix 4G and Corporate Governance Statement
	DXB DXB Ann: Appendix 4E and 2022 Annual Report
	DXB DXB Ann: CLARITY 2.0 COVID-19 Study Concludes Recruitment
	DXB DXB Ann: Notification of cessation of securities - DXB
	DXB DXB Ann: New Patent Family Application for DMX-700
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: Notification regarding unquoted securities - DXB
	DXB DXB Ann: DMX-700 Study Shows Significant 80% Reduction in Lung Injury
	DXB DXB Ann: REMAP-CAP COVID-19 Study Analysis Update
	DXB DXB Ann: New Clinical Trial for DMX-200 in Diabetic Kidney Disease
	DXB DXB Ann: Dimerix to Present at BIO International Convention
	DXB DXB Ann: Phase 3 FSGS Kidney Trial First Patient Recruited
	DXB DXB Ann: Release of Shares from Voluntary Escrow
	DXB DXB Ann: Dimerix presentation at Bioshares Biotech Summit
	DXB DXB Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: Dimerix Receives A$3.7M R&D Tax Incentive Rebate
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Dimerix Investor Call and Presentation
	DXB DXB Ann: DSMB Change to REMAP-CAP COVID-19 Study
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Half-Year Financial Report & Appendix 4D - 31 December 2021
	DXB DXB Ann: Dimerix Appoints Chief Medical Officer
	DXB DXB Ann: First Regulatory Approval in Europe for DMX-200 FSGS Study
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
	DXB DXB Ann: Ethics Approval in Australia for Phase 3 COVID-19 Study
	DXB DXB Ann: Dimerix Receives Further MRFF Funding for DMX-200
	DXB DXB Ann: DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe
	DXB DXB Ann: Pause in Trading
	DXB DXB Ann: Notification regarding unquoted securities - DXB
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: First Approvals Received for Start of Phase 3 FSGS Trial
	DXB DXB Ann: Phase 3 DMX-200 COVID-19 Study Expands into Australia
	DXB DXB Ann: Change in substantial holding
	DXB DXB Ann: Becoming a substantial holder
	DXB DXB Ann: Secondary Trading Notice Pursuant to Section 708A(5)(e)
	DXB DXB Ann: Change of Director's Interest Notices - JW, HA, SP and NW
	DXB DXB Ann: Notification regarding unquoted securities - DXB

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
05-Aug	$0.29	3,000,609	0.00 (0.00%)
04-Aug	$0.29	2,765,416	+0.03 (11.54%)
03-Aug	$0.26	1,570,379	+0.02 (6.12%)
31-Jul	$0.25	782,736	-0.01 (2.00%)
30-Jul	$0.25	799,927	+0.01 (4.17%)
29-Jul	$0.24	1,353,946	-0.01 (4.00%)
28-Jul	$0.25	2,169,136	+0.01 (2.04%)
27-Jul	$0.25	265,681	-0.01 (2.00%)
24-Jul	$0.25	1,091,226	+0.01 (4.17%)
23-Jul	$0.24	2,448,999	-0.01 (4.00%)
22-Jul	$0.25	1,986,809	+0.02 (8.70%)
21-Jul	$0.23	688,279	+0.01 (2.22%)
20-Jul	$0.23	2,190,009	-0.02 (6.25%)
17-Jul	$0.24	6,415,709	-0.30 (55.14%)
18-Sep	$0.54	1,071,324	+0.02 (3.88%)
8 up, 6 down, and 1 flat days

Dimerix Health Care
Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Dimerix Health Care Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Dimerix Health Care
Biotech Healthcare Pharmaceuticals